Skip to main content
Signal8

Nelson Jennifer Ann

SEC insider (Form 3/4/5 filer). CIK 0002046425. Chief Scientific Officer at Omega Therapeutics, Inc. (OMGA). 1 reported Form 4/5 transaction since Sep 2024; latest on Nov 22, 2024. Located in CAMBRIDGE, MA.

Companies Nelson Jennifer Ann has filed insider reports for

  • Omega Therapeutics, Inc. (OMGA): Officer, Chief Scientific Officer
Nelson Jennifer Ann profile photo

Nelson Jennifer Ann

CIK: 0002046425

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Omega Therapeutics, Inc. logo
OMGA

Omega Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Omega Therapeutics, Inc. logo
    OMGA

    Omega Therapeutics, Inc.

    Nov 22, 2024
    Award

    Stock Option (Right to Buy)

    Direct
    110K shares-

1-1 of 1